MedPath

Effect of zinc adminesteration to controling of blood suger in diabetic patients

Phase 2
Conditions
Diabetes mellitus.
Insulin-dependent diabetes mellitus
Registration Number
IRCT138901303596N2
Lead Sponsor
Jundishapur University of Ahvaz-research deputy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

type 1 diabetic patients; Exclusion criteria: sensitivity to zinc sulfate and HbA1C <6.5

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c level. Timepoint: At the baseline and 3 month later. Method of measurement: HPLC method.
Secondary Outcome Measures
NameTimeMethod
Serum zinc. Timepoint: At the baseline and 3 month later. Method of measurement: atomic absorption spectrophotometry.
© Copyright 2025. All Rights Reserved by MedPath